Computer-Assisted versus Oral-and-Written History Taking for the Prevention and Management of Cardiovascular Disease: a Systematic Review of the Literature by Pappas, Yannis et al.
Open Research Online
The Open University’s repository of research publications
and other research outputs
Computer-Assisted versus Oral-and-Written History
Taking for the Prevention and Management of
Cardiovascular Disease: a Systematic Review of the
Literature
Journal Item
How to cite:
Pappas, Yannis; Vsˇetecˇkova´, Jitka; Poduval, Shoba; Tseng, Pei Ching and Car, Josip (2018). Computer-Assisted
versus Oral-and-Written History Taking for the Prevention and Management of Cardiovascular Disease: a Systematic
Review of the Literature. Acta Medica, 60(3) pp. 97–107.
For guidance on citations see FAQs.
c© 2017 The Authors
Version: Version of Record
Link(s) to article on publisher’s website:
http://dx.doi.org/doi:10.14712/18059694.2018.1
https://actamedica.lfhk.cuni.cz/online first/am 2017060030097/
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
review article 97
Computer-Assisted versus Oral-and-Written 
History Taking for the Prevention  
and Management of Cardiovascular Disease:  
a Systematic Review of the Literature
Yannis Pappas1, Jitka Všetečková2,*, Shoba Poduval3, Pei Ching Tseng1, Josip Car4
Acta Medica (Hradec Králové) 2017; 60(3): 97–107
https://doi.org/10.14712/18059694.2018.1
© 2017 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License  
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,  
provided the original author and source are credited.
A B S T R AC T
Background and objectives: CVD is an important global healthcare issue; it is the leading cause of global mortality, with an increasing 
incidence identified in both developed and developing countries. It is also an extremely costly disease for healthcare systems unless 
managed effectively. In this review we aimed to:
– Assess the effect of computer-assisted versus oral-and-written history taking on the quality of collected information for the prevention 
and management of CVD.
– Assess the effect of computer-assisted versus oral-and-written history taking on the prevention and management of CVD.
Methods: A systematic review of randomised controlled trials that included participants of 16 years or older at the beginning of the study, 
who were at risk of CVD (prevention) or were either previously diagnosed with CVD (management). We searched all major databases. We 
assessed risk of bias using the Cochrane Collaboration tool.
Results: Two studies met the inclusion criteria. One comparing the two methods of history-taking for the prevention of cardiovascular 
disease n = 75.  
The study shows that generally the patients in the experimental group underwent more laboratory procedures, had more biomarker 
readings recorded and/or were given (or had reviewed), more dietary changes than the control group. The other study compares the two 
methods of history-taking for the management of cardiovascular disease (n = 479). The study showed that the computerized decision aid 
appears to increase the proportion of patients who responded to invitations to discuss CVD prevention with their doctor. The Computer-
Assisted History Taking Systems (CAHTS) increased the proportion of patients who discussed CHD risk reduction with their doctor from 
24% to 40% and increased the proportion who had a specific plan to reduce their risk from 24% to 37%.
Discussion: With only one study meeting the inclusion criteria, for prevention of CVD and one study for management of CVD we did 
not gather sufficient evidence to address all of the objectives of the review. We were unable to report on most of the secondary patient 
outcomes in our protocol.
Conclusions: We tentatively conclude that CAHTS can provide individually-tailored information about CVD prevention. However, further 
primary studies are needed to confirm these findings. We cannot draw any conclusions in relation to any other clinical outcomes at this 
stage. There is a need to develop an evidence base to support the effective development and use of CAHTS in this area of practice. In 
the absence of evidence on effectiveness, the implementation of computer-assisted history taking may only rely on the clinicians’ tacit 
knowledge, published monographs and viewpoint articles.
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BACKGROUND
Cardiovascular Disease (CVD) is caused by a disorder of 
the heart and circulatory system. In this review we are 
specifically looking at atherosclerotic cardiovascular dis-
ease which includes coronary heart disease, cerebrovas-
cular disease (stroke) and peripheral artery disease. CVD 
is a  leading cause of mortality globally. Chronic diseas-
es, including cardiovascular disease, were estimated to 
cause more than 60% (35 million) of all deaths in 2005; 
more than 80% of these deaths occurred in low-income 
and middle-income countries (31). According to the 2010 
Global Burden of Disease Study (58) ischaemic heart dis-
ease and stroke killed 12.9 million people in 2010, or one 
in four deaths worldwide, compared with one in five in 
1990. The World Health Organisation projects that by 2030, 
almost 23.6 million people will die from CVD (10). The risk 
of developing vascular disease and the rate of its progres-
sion is determined by certain ‘fixed’ risk factors: age, sex, 
family history of vascular disease and ethnic groups, as 
well as by certain ‘modifiable’ risk factors: hypertension, 
hypercholesterolaemia, physical inactivity, obesity, tobac-
co consumption and diabetes (51). Ineffective management 
of CVD associated modifiable risk factors can lead to an 
increased risk of an adverse cardiovascular event. People 
with established CVD (such as angina pectoris, CHD, my-
ocardial infarction, transient Ischaemic attacks, stroke or 
peripheral vascular disease) are at high risk of developing 
recurrent cardiovascular events; it is possible to prevent 
this by reducing a patient’s cardiovascular risk by mod-
ification of adverse lifestyle behaviours and adhering to 
treatment, thus enabling effective management of their 
chronic condition (59, 33). 
CAHTS facilitate automations of history taking ap-
proaches; hence aiding the collection of information in 
a timely manner by drastically reducing the time spent on 
dictating and collating written records, while being able to 
present relevant data in an easily accessible format (50, 4). 
They can also be administered at a time that is convenient 
to the patient and practitioner, saving resources, such as 
additional time and space (57, 30). Additionally, CAHTS can 
promote inter-operability between systems and compatibil-
ity with electronic health record templates (40). This offers 
the benefit that the information collected could be linked to 
a computerized decision support system which can offer pa-
tients personalized feedback on their lifestyle choices and 
advice on how to modify these to reduce their risk of devel-
oping or redeveloping cardiovascular related complications.
Clinician and patient-operated CAHTS may help to im-
prove data quality through:
–  data entry forms with data validation checks (for ex-
ample erroneously entered information, such as age of 
300, may lead to a prompt for the person to correct this;
–  coding of data;
–  eliminate transcription errors as the information is not 
dictated;
–  legibility;
–  easier access to past records; attribution of entries;
–  greater availability;
–  facilitating patient verification of their personal infor-
mation.
Patients can also administer the CAHTS online and on 
lifestyle and self-generated biomarker readings (for ex-
ample, blood pressure or blood cholesterol) can be shared 
with their clinician and assessed without the need for 
a face to face consultation. Additionally, collected infor-
mation from gathered histories can generate data sets that 
may facilitate future epidemiological research (34).
CVD is an important global healthcare issue; it is the 
leading cause of global mortality, with an increasing inci-
dence identified in both developed and developing coun-
tries. CVD is an extremely costly disease for healthcare 
systems and unless managed effectively, will continue 
to pose serious challenges to these systems and to the al-
location of scarce resources (9). Evidence suggests that 
current programmes for cardiovascular management of-
fer feasible, cost-effective ways to reduce CVD mortality 
and morbidity in both developed and developing country 
populations (10, 23); implementation of such programmes 
should thus be a priority for health policy-makers. With 
the move from hospital care to community-based care in 
many parts of the world, staff become increasingly mo-
bile, thus require access to data input facilities at the point 
of care. If a patient’s history were taken by a CAHTS, the 
information could be more accessible to the entire, mul-
ti-disciplinary, healthcare team and assist in the planning 
of an appropriate care package for the patient.
Most of the computer-assisted technologies are pres-
ently supported by limited empirical evidence. This im-
pedes widespread adoption in the management and pre-
vention of CVD, hence necessitating more evaluations 
of CAHTS. There is also a need for regular evaluations, 
analogous to techniques used in continuous quality im-
provement in healthcare (36, 1, 11). Unless these systems 
are adequately studied, they may not ‘mature’ to the ex-
tent that is needed to realise their full potential when de-
ployed in every-day clinical settings (18, 15). Because only 
a few randomised controlled trials involving CATHS have 
been performed so far, it has been speculated that the im-
provements in the volume and accuracy of the answers 
seen in studies (34, 57, 24) may not accurately reflect the 
intervention. It has been suggested that the effects may 
be attributed to novelty and performance biases whereby 
the behaviour of researchers and patients was influenced 
(24). 
CAHTS are frequently promoted as being ‘cost-saving’ 
(26, 45), yet cost-effectiveness and efficiency was rare-
ly evaluated rigorously (37), therefore comprehensive 
cost-effectiveness analyses will be required to assess the 
financial rationale for choosing one CAHTS over another 
history taking tool, especially within disease manage-
ment (45, 28). Although CAHTS have been available for 
around 50 years, successful use in routine healthcare 
remains variable. This review aims to establish whether 
these systems could be effective for the management of 
CVD, by assisting patient adoption of lifestyle modification 
behaviour and assisting treatment adherence, and identify 
any gaps in the research surrounding this. This systemat-
ic review involves an up-to-date literature search and de-
tailed description of the studies on CAHTS to provide the 
framework for a comprehensive evaluation that will lead 
to an evidence base to inform policy and practice.
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METHODS
TYPES OF STUDIES AND PARTICIPANTS
We considered RCT studies that included participants 
16 years or older at the beginning of the study, who were 
at risk of CVD (prevention) and those who were previously 
diagnosed with CVD (management).
TYPES OF INTERVENTIONS
We considered the following six types of CAHTS:
1. Computer-assisted self-interviewing;
2.  Audio computer-assisted self-administered interview-
ing;
3. Computer-assisted face-to-face interviewing;
4. Computer-assisted telephone interviewing;
5. Interactive voice response telephone interviewing;
6. Internet-based computer-assisted history taking.
CONTROL
Oral and written history taking for people with modifiable 
CVD risk factors (prevention) and those diagnosed with 
CVD (management).
OUTCOMES 
Primary outcomes:
–  Response rates to invitations for (lifestyle) assessment 
for CVD.
–  Quality of data recorded (Composite outcome includ-
ing: error rates, accuracy, reliability, completeness).
–  Lifestyle modifications (Composite outcome including: 
changes in tobacco consumption (pack years), weight 
(kg), dietary intake (self-reported intake), physical ac-
tivity level (number of days a week patient participates 
in physical activity); Biomarker reading modifications 
(Composite outcome including: changes in blood cho-
lesterol levels (total cholesterol in mg/dl), blood pres-
sure readings (mmHg), glycosylated haemoglobin A1c 
level (mm/mol)).
Secondary outcomes
–  Cost effectiveness.
–  Patient and provider satisfaction with the methods.
–  Adverse events (Composite outcome including: CVD 
mortality and morbidity).
–  Response rates to invitations for (lifestyle) assessment 
or CVD; Patient compliance with treatment.
–  Biomarker readings (Composite outcome: includes 
changes in blood cholesterol levels, blood pressure 
readings and glycosylated haemoglobin A1c level).
–  Cost effectiveness.
–  Patient and provider satisfaction with the methods.
–  Adverse events (Composite outcome: includes car-
diovascular-related mortality (i.e. death due to CHD 
or stroke), increased cardiovascular-related morbidity 
(i.e. increased recurrence of a  cardiovascular event) 
and hospitalisation due to a cardiovascular event).
SEARCH METHODS FOR IDENTIFICATION OF STUDIES 
We searched electronically the following sources for the 
identification of trials on 18 June 2016:
–  CENTRAL (Issue 5 of 12, 2016) on The Cochrane Li-
brary,
–  MEDLINE (OVID, 1946 to June 2016 week 1),
–  EMBASE (OVID, 1980 to 2016 week 24),
–  Web of Science Core Collection (Thomson Reuters, 1970 
to 13 June 2016),
–  DARE, HTA and EED (Issue 2 of 4, 2016) on The Cochrane 
Library.
We imposed no language limits. The Cochrane preci-
sion-maximising RCT filter was used for MEDLINE and 
terms as suggested as a RCT filter for EMBASE (14).
We also used the following other resources for the 
identification of trials:
–  ‘Current Controlled Trials’ (www.controlledtrials.com),
–  Clinical Trials.gov (www.clinicaltrials.gov),
–  WHO ICTRP Portal (apps.who.int/trialsearch).
We tried to identify additional studies by searching 
the reference lists of included trials, related (systematic) 
reviews and meta-analyses. Authors of included studies 
were contacted for further details (if required) and au-
thors and experts in the field were asked for information 
about unpublished/ongoing trials.
DATA COLLECTION AND DATA EXTRACTION
To determine the studies to be assessed further, three 
authors (SP, JV and YP) independently scanned the ab-
stract, title or both sections of every record retrieved. 
All potentially relevant articles were investigated as full 
text. Where differences in opinion existed, they were re-
solved by a third party. If resolving disagreement was not 
possible, the article were added to those ‘awaiting assess-
ment’ and authors were been contacted for clarification. 
An adapted PRISMA (Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses) flow-charts of study 
selection is attached (19) see Figures 1 and 2.
For studies that fulfilled inclusion criteria, two authors 
(SP and PT) independently abstracted relevant population 
and intervention characteristics using standard data ex-
traction templates with any disagreements resolved by 
discussion, or if required by a third party. Any relevant 
missing information on the trial was sought from the 
original author(s) of the article, if required. Authors and 
experts in the field were asked for information about un-
published/ongoing trials.
ASSESSMENT OF RISK OF BIAS IN INCLUDED STUDIES
Two authors assessed each trial and performed assess-
ment of bias independently. Disagreement was resolved 
by consensus, or with consultation of a third party.
We assessed risk of bias using the Cochrane Collabora-
tion’s tool. We used the following criteria:
–  Was the allocation sequence adequately generated? 
Was the allocation adequately concealed?
–  Was knowledge of the allocated intervention adequate-
ly prevented during the study? Were incomplete out-
come data adequately addressed?
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–  Were reports of the study free of suggestion of selec-
tive outcome reporting?
–  Was the study apparently free of other problems that 
could put it at a high risk of bias?
We assessed the risk of bias as high, low or unclear. 
We used the criteria described in the Cochrane Hand-
book for Systematic Reviews of Interventions (19). Funnel 
plots were to be used to assess for the potential existence 
of small study bias. As a number of explanations for the 
asymmetry of a funnel plot (27) exist, we planned to care-
fully interpret results (13).
MEASURES OF TREATMENT EFFECT
We collected endpoint scores, as change standard devia-
tions may not be available for many studies. If both end-
point and change scores are available for the same out-
comes, only the former was reported in this review. If 
endpoint scores are not available, but change scores are, we 
reported the latter in the tables and text of the review. How-
ever, for inclusion of a study reporting change score in the 
meta-analysis, we calculated the endpoint mean from the 
change score given and assumed that the endpoint stand-
ard deviation is equal to the baseline standard deviation. 
We also took into account the level at which randomisation 
occurred, such as cross-over trials, cluster-randomised 
trials and multiple observations for the same outcome.
There were no missing data in the included studies. 
Evaluation of important numerical data such as screened, 
randomised patients as well as intention-to-treat and 
per-protocol population was carefully performed. Attri-
tion rates, for example drop-outs, losses to follow-up and 
withdrawals were investigated. Issues of missing data 
and techniques to handle these (for example, last-obser-
vation-carried-forward) was critically appraised.
ASSESSMENT OF HETEROGENEITY
The review included two studies one on the prevention of 
CVD and one on the management of CVD and no assess-
ment of heterogeneity was needed. Results of the studies 
included were presented in narrative form.
RESULTS
Results were divided into two categories according the 
main use of CAHTS:
–  CVD Prevention,
–  CVD Management.
These two categories are reflected in the objectives of 
the review and the search strategy.
PREVENTION
Results of the search
The search identified 97881 records for screening; 76182 
after removing duplicates. The titles of  the records 
were screened by two authors. 127 records were further 
screened by abstract and 15 were retrieved in full text. One 
record met the inclusion criteria of the review. Reasons for 
excluding the abstracts included: participants not having 
Fig. 1: Flowchart of studies in CVD prevention. 
 
	  
Fig. 1: Flowchart of studies in CVD prevention.
Fig. 2: Flowchart of studies in CVD management. 
 
 
	  Fig. 2: Flowchart of studies in CVD management.
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pre-existing cardiovascular disease, no computer-assisted 
history taking systems being used as intervention, or the 
studies were not randomized controlled trials. See Figure 1 
for a detailed search strategy.
For included studies see Table 1. One study (43) met our 
inclusion criteria, the details of which can be found in 
Characteristics of included studies. For excluded studies 
see Table 3.
Tab. 1: Characteristics of included studies (CVD prevention).
Author Reasons for inclusion
Sheridan et al. (2006)
This study was used to test the effectiveness of an individually-tailored, computerized decision aid about 
CHD on patients’ discussions with their doctor and their plans for CHD prevention.
Participants were identified from daily clinician schedules and after obtaining clinician’s permission, they 
were approached about the study in the waiting room or in the exam room as they waited for their sched-
uled visit. 75 adults were enrolled. 41 received decision aid, 34 usual care.
After assessing baseline characteristics, all patients in the intervention group were asked to review the 
computerized decision aid, Heart to Heart. 
Heart to Heart 1) calculates a patient’s global risk of CHD events (e.g. angina, myocardial infarction, and 
death) in the next 10 years by combining information about their age, sex, blood pressure, total and HDL 
cholesterol, smoking, diabetes and left ventricular hypertrophy status using a continuous Framingham 
equation. 2) provides patients with individualized information about their global CHD risk, their personal 
risk factors, the pros and cons of pertinent CHD risk-reducing therapies (e.g. hypertension medication, 
cholesterol medication, smoking cessation and aspirin), and the risk reduction achievable after one or more 
therapeutic interventions 3) encourages patients to choose therapies that are acceptable and feasible for 
long-term CHD risk reduction.It also provides a summary print-out that can be taken to one’s visit with his 
or her doctor.
The patients navigated the decision aid at their own speed. A research assistant was available at all times to 
answer any questions.
Tab. 1.1: Risk of bias.
Sheridan et al. (2006)
Type of bias Severity of bias Support for judgement 
Random sequence generation  
(selection bias)
Low risk Quote: We used a computerized random number generator to randomize 
patients to receive either the Heart to Heart decision aid or a list of their 
CHD risk factors that they could present to their doctor.
Allocation concealment  
(selection bias)
Low risk Quote: Intervention assignments were sealed in security envelopes until 
after subjects agreed to participate in the study. The research assistant then 
broke the seal to determine intervention assignment.
Blinding (performance bias and  
detection bias)
Low risk Participants were blinded.
Blinding of outcome assessment  
(detection bias)
High risk The research team weren’t blinded
Incomplete outcome data  
(attrition bias)
Low risk Twelve patients (8 in the decision aid group and 4 in the control group) 
were subsequently determined to be ineligible with those in the decision 
aid group being slightly more likely to be male and younger. These individu-
als were excluded from further analyses
Selective reporting (reporting bias) Low risk No selective reporting was detected.
Other bias Low risk None identified
Effects of interventions in CVD prevention
75 adults were enrolled. 41 patients received the deci-
sion aid and 34 received usual care The main effect of 
the decision aid on decision making was measured in 
2  ways: 1) by the proportion of patients who reported 
they discussed CHD risk with their doctor, and 2) by the 
proportion of patients that talked with their doctor who 
reported they had a specific plan for CHD risk reduction 
at the post-visit survey. Sheridan et al. (2006) measured 
patient discussions with their doctor through a  single 
question: “Did you and your doctor discuss a plan to low-
er your chances of having a heart attack?” Sheridan et al. 
(2006) measured plans for CHD risk reduction through 
a single question: “At the end of your visit, what did you 
decide to do, if  anything, to lower your chances of heart 
disease?” Sheridan et al. (2006) considered stated intent 
to adopt any CHD risk reducing behaviour (i.e. aspirin, 
lipid lowering medication, antihypertensive medication, 
smoking cessation medications, dietary change, or exer-
cise) in the next 6 months as sufficient evidence of a plan 
for CHD risk reduction.
In unadjusted analysis, the decision aid increased 
the proportion of patients who discussed CHD risk re-
duction with their doctor from 24% to 40% (absolute 
difference 16%; 95% CI −4% to +37%). In pre-post testing, 
the decision aid also appeared to increase the propor-
tion of  patients with plans to intervene on their CHD 
risk through initiating aspirin, lipid lowering medica-
tion, antihypertensive medication, smoking cessation 
medication, dietary change or exercise. The study did 
not look at the other outcome measures included in our 
protocol including quality of  the data recorded, life-
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style modifications, biomarker reading modifications, 
cost effectiveness, patient and provider satisfaction or 
adverse events.
MANAGEMENT
Results of the search
The search identified 50151 records from databases and 
3282 from other resources, giving a total of 53433 records 
for screening. The titles of the records were screened by 
two authors (YP, SP). 127 records were further screened 
by abstract and 14 were retrieved in full text. One re-
cord met the inclusion criteria of the review. Reasons for 
excluding the abstracts included: participants not having 
pre-existing cardiovascular disease, no computer-assisted 
history taking systems being used as intervention, or the 
studies were not randomized controlled trials. See Fig-
ure 2 for more detailed flow of our searches.
For included studies see Table 2. One study, Rogers et 
al. met the inclusion criteria. Details of the study can be 
found in Characteristics of included studies. For excluded 
studies see Table 3.
Tab. 2: Characteristics of included studies (CVD management).
Author Reasons for inclusion
Rogers et al.  
(1982)
This study describes the influence of a computerized medical record summary system in three disease areas (hyper-
tension, obesity and renal disease) observed in the course of a controlled, randomized and prospective study  
of 479 Northwestern University Cardiac, Pulmonary and Renal Clinic (NUCPRC) patients.
From 1,200 eligible patients, 484 were randomly selected and assigned to either the experimental or control group. 
241 participants were assigned to the experimental group and 238 in the control group. Five participants withdrew 
from the study before it began.
The NUCPRC developed a computerized medical record system (NUCRSS) to provide physicians with concise and 
current information on patients’ problems, to identify omissions in recording of observations and treatment recom-
mendations, to show ordered procedures that were not carried out, to record deficiencies in medical reasoning and, 
most importantly, to recommend corrective actions according to selected criteria.
In the experimental group, patients had available a computer printout of a current NUCRSS summary in addition to 
the traditional medical record, while the control group had available only the handwritten, traditional medical  
record.
Hypertension: examination of the renal function occurred more frequently during both years of the study I n the 
experimental group (120 times in experimental group and 93 times in control group). There was little difference in 
distributions across conditions for either the fundusopic examination (14 vs 9) or the intravenous pyelogram  
(78 vs 59). 
Obesity: failure to give or review a diet at any time during the two-year study period clearly occurred less often among 
experimental patients (number of diets given or reviewed: 23 in experimental group and 16 in control group).
Renal disease: there were fewer experimental patients who had not had a urine analysis performed either year, while 
more experimental patients had tests performed both years (30 vs 14).
Tab. 2.1: Risk of bias.
Type of bias – Rogers et al. 
(1982)
Severity of bias Author
Random sequence genera-
tion (selection bias)
High risk Rogers et al. (1982) stated the randomization process was performed as follows: From 
1,200 eligible patients, 484 were selected and assigned to either an experimental 
or control group. It is not clear whether the participants were randomly selected or 
assigned to a group.
Allocation concealment 
(selection bias)
High risk As above
Blinding (performance 
bias and detection bias)
Unclear risk In the experimental group, patients had a computer printout of a current North wester 
University computerized medical record system summary (NUCRSS) in addition to the 
traditional medical record, while the control group had only the handwritten, traditional 
medical record.
Physicians participating in the study were randomly divided into three groups: 1) those 
that were only to see patients with automated records available; 2) those who were to 
see patients without automated records; and 3) those whose patient load was approxi-
mately half with and half without automated records. It would therefore not have been 
possible to blind participants or physicians to their allocation.
Blind retrospective chart reviews were done one and two years after the entry of  
patients into the study for both experimental and control patients by trained personnel 
using a standardised evaluation form.
Incomplete outcome data 
(attrition bias)
Unclear risk Rogers et al. (1982) reported the number and percentage of patients who died by the 
end of the two-year study period or were transferred to another clinic, moved or left 
for unknown reasons. Differential dropout rates across conditions due to death or 
other reasons were not presented.
Selective reporting  
(reporting bias)
Low risk None identified
Other bias Low risk None identified
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EFFECTS OF INTERVENTIONS IN CVD MANAGEMENT
The effects of the interventions in the Rogers et al. 
(1982) study were measured according to the perfor-
mance of selected annual medical tests and procedures 
that were considered to be essential for the care of pa-
tients with hypertension, obesity and renal disease. 
These were blood tests for renal function, electrolytes, 
fundoscopy and intravenous pyelogram for hyperten-
sion. Urine analysis and culture was also checked for the 
renal patients. Obese patients were given diet informa-
tion or had their diet reviewed. The details of the diet 
were not reported.
Tab. 3: Characteristics of excluded studies.
Author Reason for exclusion
Baer et al. (2012) Full text of this study was not available, even after contacting the authors.
Bulpitt et al. (1976) Investigation results not often present in the notes.
Davis et al. (2010) Experimental group not computer-assisted history-taking.
Gill et al. (2009) Electronic health records used in both groups.
Khambatta et al. (2011) Not RCT.
Lowensteyn et al. (1988) Control group only received cardiovascular risk profile if the patient was clinically re-evaluated during 
a 3 month follow-up visit.
Ruffin et al. (2011) Familial risk assessed only.
Sequist et al. (2011) Electronic health records used in both groups.
Sequist et al. (2012) The aim is to identify subsequent actions following a risk alert. This outcome is not included in our 
protocol.
Sheridan et al. (2006) Study participants did not have a history of cardiovascular disease.
Sheridan et al. (2011) Study participants did not have a history of cardiovascular disease.
Van Wyck et al. (2003) Abstract prospective, full article not located.
Wakefield et al. (2012) Study does not compare electronically gathered data to data gathered in oral and/or written form.
PRIMARY OUTCOMES FOR PREVENTION  
AND MANAGEMENT
Quality of data recorded (Composite outcome: includes er-
ror rates, completeness, accuracy, reliability) and lifestyle 
modifications (Composite outcome: includes changes in 
tobacco consumption, weight, dietary intake and physical 
activity levels): the results of the study show that gener-
ally the patients in the experimental group underwent 
more laboratory procedures, and/or were given (or had 
reviewed), more diets than the control group. There was 
a statistically significant difference in the number of hy-
pertensive patients who had their renal function checked, 
the number of diets given or reviewed for obese patients, 
and the number of urine cultures checked for patients 
with renal disease. These are all tests that are considered 
essential for high quality, routine care of patients with 
cardiovascular disease. The results therefore suggest that 
computer-assisted methods of history-taking are more ef-
fective for the management of cardiovascular disease.
The paper does not comment on adverse effects but 
does describe mortality rates. About a  third of patients 
died of hypertension (28% in the experimental group and 
33% in the control group). 10% died in the renal group (10% 
of both the experimental and control group). 8% died in 
the obesity group (1% of the experimental group and 7% 
of the control group).
RISK OF BIAS IN INCLUDED STUDIES (TABLE 2.1)
Overall the risk of bias for Sheridan et al. was low. The risk 
of bias for Rogers et al. (1982) was high. 
DISCUSSION
Discussion is divided into two categories according to the 
aims and initial searches. The two categories are:
–  CAHTS for CVD Prevention,
–  CAHTS for CVD Management.
CAHTS FOR CVD PREVENTION
The comprehensive search strategy for studies on the use of 
CAHTS for CVD prevention yielded 97881 results, of which 
one met our inclusion criteria. A  randomized trial was 
carried out to test the effectiveness of an individually-tai-
lored, computerized decision aid about CHD on patients’ 
discussions with their doctor and their plans for CHD pre-
vention. A computerized random number generator was 
used to randomize patients to receive the intervention, 
the computerised Heart to Heart decision aid, or the con-
trol which was a list of their chronic heart disease (CHD) 
risk factors that they could present to their doctor. This 
list included qualitative identification of the risk factors 
and, where appropriate, a quantitative value for the fol-
lowing risk factors: blood pressure, total and HDL choles-
terol, smoking, diabetes, and left ventricular hypertrophy 
(LVH) status. The computerized decision aid allows com-
puter-assisted history-taking of patients’ CVD risk factors. 
For more information on how it uses this information see 
Table 1. 75 adults were enrolled. 41 patients received the 
decision aid and 34 received usual care. The main effect 
of the decision aid on decision making was measured in 2 
ways: 1) by the proportion of patients who reported they 
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discussed CHD risk with their doctor, and 2) by the pro-
portion of patients that talked with their doctor who re-
ported they had a specific plan for CHD risk reduction at 
the post-visit survey. Sheridan et al. (2006) measured pa-
tient discussions with their doctor through a single ques-
tion: “Did you and your doctor discuss a plan to lower your 
chances of having a heart attack?” Similarly, Sheridan et 
al. (2006) measured plans for CHD risk reduction through 
a single question: “At the end of your visit, what did you 
decide to do, if anything, to lower your chances of heart 
disease?” Sheridan et al. (2006) considered stated intent to 
adopt any CHD risk reducing behaviour (i.e. aspirin, lipid 
lowering medication, antihypertensive medication, smok-
ing cessation medications, dietary change, or exercise) 
in the next 6 months as sufficient evidence of a plan for 
CHD risk reduction. In unadjusted analysis, the decision 
aid increased the proportion of patients who discussed 
CHD risk reduction with their doctor from 24% to 40% 
(absolute difference 16%; 95% CI −4% to +37%). In pre-post 
testing, the decision aid also appeared to increase the pro-
portion of patients with plans to intervene on their CHD 
risk through initiating aspirin, lipid lowering medication, 
antihypertensive medication, smoking cessation medica-
tion, dietary change or exercise. Overall assessment of risk 
of bias was low. There are no other reviews on the use of 
CAHTS for the prevention of cardiovascular disease. Other 
studies (43, 53, 41, 32, 54, 7) assessed the use of CAHTS on 
cardiovascular disease prevention and management, but 
these either did not compare oral to written history taking 
processes or were conducted in participants who did have 
pre-existing cardiovascular disease. In agreement with 
our findings they generally found that computer-assisted 
methods improved the prevention or management of pa-
tients with cardiovascular disease or with risk factors for 
cardiovascular disease.
CAHTS FOR CVD MANAGEMENT
The comprehensive search strategy for studies on the use 
of CAHTS for CVD management yielded 50151 results, 
of which one met our inclusion criteria (39) This study 
is a randomized, controlled prospective study looking at 
the influence of a computerized medical record summary 
system in three disease areas (hypertension, obesity and 
renal disease) in 479 Northwestern University Clinic pa-
tients. Patients in the experimental group had computer-
ised record summaries whilst patients in the control group 
had only a hard copy medical record. They were compared 
on several medical tests and procedures whose yearly oc-
currence was considered good medical practice for this 
patient population. These were blood tests for renal func-
tion, electrolytes, fundoscopy and intravenous pyelogram 
for hypertension. Urine analysis and culture was also 
checked for the renal patients. Obese patients were given 
diet information or had their diet reviewed. The details of 
the diet were not reported. For more detailed information 
please see Table 2. The results of the study show that gen-
erally the patients in the experimental group underwent 
more laboratory procedures, and/or were given (or had 
reviewed), more diets than the control group. These labo-
ratory procedures give the biomarker readings which are 
stated in our protocol as appropriate outcome measures 
for our review.
Rogers et al. (1982) also reports that the traditional 
non-computerised records used in the clinics contained an 
average of 1.5 pounds of notes, laboratory test outcomes, 
diagnoses and other information not entered over long 
periods of time by the physicians. This may have affected 
continuity of care, especially as patients were not neces-
sarily seen by the same physician from visit to visit. The 
same authors further noted that the computerised infor-
mation system condensed the records to items that were 
current and relevant, providing physicians with warnings 
and reminders about good medical practices. These com-
ments regarding the medical records provide evidence for 
quality of data, a further outcome measure stated in our 
protocol.
Traditionally a patient’s history is taken by oral-and-
written methods; however, it can also be taken using 
computers. Although computer-assisted history taking 
systems (CAHTS) have been available (in various forms) 
since the 1960s (2), wide and systematic adoption in rou-
tine delivery of healthcare remains variable. CAHTS, such 
as a web-based questionnaire or interactive touch screen 
monitors, are tools used to aid clinicians in gathering in-
formation from patients. They can be used by healthcare 
professionals, or directly by patients, as in the case of pre- 
or post-consultation interviews (34, 38, 52). CAHTS can 
be used remotely, for example via the Internet, telephone 
or mobile phone messaging or on-site. Bowling (2005) de-
scribes that the various CAHTS typologies depend on three 
interrelated factors: a) the information technology used to 
collect the information (e.g. personal computer, person-
al digital assistant, Internet, telephone); b) the mode of 
administration (e.g. administered by an interviewer or 
self-administered); c) the channel of presentation (e.g. 
auditory, oral or visual). The CAHTS typologies can be clas-
sified as computer-assisted self-administering interview-
ing and audio computer-assisted self-administered inter-
viewing, computer-assisted face-to-face interviewing, 
computer-assisted telephone interviewing, interactive 
voice response telephone interviewing and Internet-based 
computer-assisted history taking. Given the social and 
psychological value ascribed to lifestyle choices, asking 
a person about these in general practice makes responses 
vulnerable to social desirability bias (a  tendency to be-
have in a way that is believed to be socially acceptable and 
desirable). Computer interviewing is effective for obtain-
ing personal information that many people find difficult 
to discuss face-to-face as the systems can collect patient 
data without the need for a face-to-face interviewer (46); 
CAHTS may therefore help to reduce the social desirabil-
ity bias in patient-reporting of harmful lifestyle choices 
or behaviors. Computers cannot however detect non-ver-
bal communication, which may be important or relevant 
for a patient’s treatment plans that could be identified in 
a face-to-face consultation (34).
There are no other reviews on the use of CAHTS for 
the management of cardiovascular disease. Other stud-
ies (17, 43, 53, 41, 54, 7, 55) assessed the use of CAHTS on 
cardiovascular disease prevention and management, but 
these either did not compare oral to written history taking 
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processes or were conducted in participants who did not 
have pre-existing cardiovascular disease. In line with our 
review they generally commented that computer-assisted 
methods improved the management of patients with car-
diovascular disease or with risk factors for cardiovascular 
disease.
Bulpitt et al. (1976) found that in three hypertension 
clinics, certain symptoms and risk factors for cardiovas-
cular disease were recognised more often when comput-
er-held records were used instead of standard hospital 
notes. Davis et al. (2010) found a  reduction in glycated 
Haemoglobin in diabetic patients when a  remote com-
prehensive diabetes self-management education inter-
vention was used. LDL cholesterol was also reduced when 
compared with usual care. Davis et al. (2010) also cites 
Hivert et al. (2009) who tested the effects of a web-based 
decision support tool, the diabetes Disease Management 
Application (DMA), developed to improve evidence-based 
management of type 2 diabetes. The number of HbA(1c) 
tests obtained per year increased significantly in the inter-
vention group compared with the control group, as did the 
number of LDL cholesterol tests and the proportions of pa-
tients undergoing at least one foot examination per year. 
Levels of HbA(1c) decreased by 0.2 in the intervention 
group and increased by 0.1 in the control group, propor-
tions of patients with LDL cholesterol levels <130 mg/dl 
increased by 20.3% in the intervention group and 10.5% 
in the control group. These results suggest that web-based 
patient-specific decision support has the potential to im-
prove the parameters of diabetes care, which is relevant to 
our research question due to their use of computer-assist-
ed decision support tools and the importance of diabetes 
as a risk factor for cardiovascular disease. If the diabetes 
can be improved with computer-assisted history taking 
this consequently impacts on the prevention of cardio-
vascular disease.
Gill et al. (2009) found improved outcomes in patients 
at high-risk of cardiovascular disease when an electronic 
form containing prompts regarding sub optimal care was 
integrated into the electronic medical record. The 3 main 
outcome variables were defined accordingly: the propor-
tion of patients tested adequately for hyperlipidaemia, 
the proportion of patients whose most recent low-density 
lipoprotein cholesterol (LDL-C) was at goal, and the pro-
portion of patients at high risk of cardiovascular disease 
with an LDL-C > 130 who were prescribed lipid-lower-
ing medications. The study showed improvements in the 
quality of lipid management after implementing an elec-
tronic disease management intervention in primary care. 
Lowensteyn et al. (1988) found improved identification of 
patients at high-risk of cardiovascular disease when com-
puter-generated risk profiles were used. Their use was 
also associated with a significantly greater improvement 
in serum lipid profiles and overall coronary risks. Ruffin 
et al. (2011) found that a  self-administered web-based 
tool that assesses familial risk for 6 common diseases in-
cluding cardiovascular disease and provides personalised 
risk-tailored messages, increased self-reporting of physi-
cal activity and healthy eating. This is consistent with the 
findings of the current study which found that experi-
mental patients had their diets reviewed more frequently 
and evidenced greater weight loss on average than con-
trol patients. Evidence of improvement in weight loss is 
relevant to our research question due to the importance 
of obesity as a risk factor for cardiovascular disease. The 
use of computer-assisted tools to increase weight loss may 
consequently help to improve cardiovascular disease pre-
vention and management. Rogers et al. (1982) also found 
that the traditional record used in the clinics contained 
on average 1.5 pounds of notes, laboratory test outcomes, 
diagnoses and other information entered over long peri-
ods of time by different physicians. The computerized sys-
tem, in addition to condensing the medical information to 
items that were current, legible and relevant, also provid-
ed physicians with warnings and reminders concerning 
good medical practices.
Our findings are consistent with other reviews on the 
use of computer-assisted history taking systems (CAHTS) 
for diabetes such as Pappas et al. (2011) which found that 
CAHTS can save professionals’ time, improve delivery of 
care to those with special needs and also facilitate the col-
lection of information, especially potentially sensitive in-
formation (e.g. sexual history, alcohol consumption). The 
findings are consistent with another systematic review, 
Wei et al. (2011) that found computer-assisted diet history 
taking to be as accurate as the oral-and-written method. 
However, this systematic review only included one study 
so we are unable to make robust conclusions.
LIMITATIONS
Biases in the review process were prevented by involving 
three reviewers in the data extraction and assessment of 
bias processes. All studies that met the initial inclusion 
criteria and were not in English were reviewed by col-
leagues who were either native speakers of the respective 
languages or bilingual. Although CAHTS can facilitate the 
history taking in several languages, it is possible that some 
patients speak none of the languages offered by the sys-
tem. 
CONCLUSIONS
In this review of the literature, we aimed to assess the ef-
fect of computer-assisted versus oral-and written histo-
ry taking on the quality of collected information for the 
prevention and management of CVD. Also, to assess the 
effect of computer-assisted versus oral-and written his-
tory taking on the prevention and management of CVD. 
We searched all major databases. We identified two stud-
ies. The limited evidence in this review shows that an in-
dividually-tailored computerized decision aid about car-
diovascular disease prevention appears to increase the 
proportion of patients who discuss cardiovascular disease 
prevention with their doctors and the proportion of pa-
tients who have a  specific plan for CHD risk reduction. 
These findings were corroborated by within group dif-
ferences that showed an increase in the perception that 
cardiovascular disease requires a personal decision and 
a specific plan for risk reduction. This might be clinical-
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ly relevant but further research evidence is needed. We 
tentatively conclude that CAHTS can provide individual-
ly-tailored information about CVD prevention. However, 
further primary studies are needed to confirm these find-
ings. There is a need to develop an evidence base to support 
the effective development and use of CAHTS in this area 
of practice. 
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